Development of simple vaccine using vitamin D3 adjuvant
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
RIKENPrincipal Investigator
Unspecified Hidehiro FukuyamaResearch Location
JapanLead Research Institution
Laboratory for Lymphocyte Differentiation, Center for Integrative Medical SciencesResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Our goal is to establish a safe and simple vaccine for COVID-19. Herd immunity requires the global community to be immunized simultaneously. We will work to develop a needle-less vaccine system by taking an advantage of our new adjuvant discovered at RIKEN.